General MedicationsORALGeneric
TETRABENAZINE
TETRABENAZINE
Standard Dose
12.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview TETRABENAZINE is listed in Drugs@FDA under application 213621 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient TETRABENAZINE Form and strength TABLET;ORAL - 12.5MG Sponsor AJANTA PHARMA LTD Submission history Latest submission status date: 2020-12-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview TETRABENAZINE is listed in Drugs@FDA under application 213621 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TETRABENAZINE Form and strength TABLET;ORAL - 12.5MG Sponsor AJANTA PHARMA LTD Submission history Latest submission status date: 2020-12-04 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.